Analytical validation of a multiplexed peptide microarray for multi-antigen Epstein–Barr virus serological profiling across diverse clinical specimens
The platform as an analytically characterized, peptide-level EBV serology tool for translational research is supported, indicating that platform-level seropositivity reflects EBV exposure rather than an obvious MS-specific signal.
Milene Peterson, J. Hunter, Z. Gatalica et al.
· Frontiers in Immunology · 0 citations